Risks And Uncertainties Include

WAYNE, BloodVitals SPO2 PA (February 24, 2016) - LifeScan, BloodVitals SPO2 Inc. has introduced the new OneTouch Verio Flex™ blood glucose monitoring system, with ColorSure™ know-how - a easy, BloodVitals SPO2 correct and simple-to-use meter that takes the guesswork out of understanding blood sugar check outcomes for individuals with diabetes. Its easy coloration range indicator makes use of shade to immediately inform patients when their blood glucose readings are "low," "in range," or "high" so they can rapidly get on with their lives. Nine out of 10 people with diabetes agreed that the meter’s color BloodVitals SPO2 vary indicator BloodVitals SPO2 helped them simply interpret their blood sugar readings. While it has broad enchantment as a simple, intuitive meter on its own, patients may use the meter’s built-in Bluetooth® Smart Technology to wirelessly join with the companion OneTouch Reveal® cell app accessible on suitable iOS and Android cell units. "Research exhibits that ease of use stays a vital reason for meter selection by a majority of patients while, at the same time, one third say they can’t make sense of their blood sugar outcomes," said Dr. Jeremy Pettus, BloodVitals SPO2 Endocrinologist and BloodVitals SPO2 Assistant Professor of Medicine at the University of California, San Diego.



"The new OneTouch Verio Flex™ meter is designed to assist individuals with diabetes better understand and handle their blood glucose. The low and high vary limits set in the OneTouch Verio Flex™ meter will be custom-made for every patient based mostly on their healthcare professional’s recommendations. With each check, the simple color range indicator exhibits whether or not a result's below restrict (blue), within vary (inexperienced) or above the restrict (red). Nine out of 10 healthcare professionals agreed that realizing when their readings are in or out of range may assist patients attain their blood sugar goals and stay in higher management. Currently, there are an estimated 29 million people with diabetes within the US and plenty of don’t test their blood sugar often or as beneficial by their healthcare professional. Seven out of 10 individuals with diabetes agreed that the OneTouch Verio Flex™ meter with its simple coloration range indicator may encourage them to test as really useful.



The OneTouch Verio®IQ meter that spots patterns and helps patients perceive how insulin, meals and way of life have an effect on their numbers. LifeScan has begun shipping the brand new OneTouch Verio Flex™ system to retailers and it will soon be available nationally wherever diabetes testing supplies are offered with an estimated retail worth of $19.99. OneTouch® is probably the most advisable brand by endocrinologists and primary care physicians. LifeScan, Inc. is a part of the Johnson & Johnson Diabetes Care Companies. With a shared vision of making a world with out limits for individuals with diabetes, the Johnson & Johnson Diabetes Care Companies is a collaboration of Johnson & Johnson companies dedicated to diabetes and includes LifeScan, Inc., a world chief in blood glucose monitoring; Animas Corporation, maker of progressive insulin delivery programs; and Calibra Medical, Inc., developer of a novel 3-day wearable insulin patch pump. Within the US, LifeScan, Inc. is the leading maker of blood glucose monitoring techniques and its OneTouch® brand products are beneficial by extra endocrinologists and main care physicians than some other model.



Globally, more than 10 million people depend upon OneTouch® brand merchandise for simple testing and correct results to assist them manage their diabetes. This press launch contains "forward-looking statements" as outlined within the Private Securities Litigation Reform Act of 1995 concerning the brand new OneTouch Verio Flex™ blood glucose monitoring system. The reader is cautioned to not rely on these ahead-wanting statements. These statements are primarily based on present expectations of future occasions. If underlying assumptions show inaccurate or recognized or unknown dangers or uncertainties materialize, actual outcomes may vary materially from the expectations and projections of LifeScan, Inc. and/or Johnson & Johnson. Risks and uncertainties embody, but aren't restricted to: uncertainty of economic success; challenges to patents; competitors, including technological advances, new merchandise and patents attained by rivals; changes to relevant laws and rules, including global well being care reforms; adjustments in behavior and spending patterns or financial distress of purchasers of well being care services and products; product efficacy or safety concerns resulting in product recalls or regulatory motion; manufacturing difficulties and delays; and traits towards health care price containment.